Month: August 2021

Telemedicine appointments combined with in-person visits significantly reduced the risk of further illness for children with medically complex cases, according to results of a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth). The study was published today in Pediatrics. Children with medically complex cases require intense care supervision
0 Comments
Since the COVID-19 pandemic reached the United States in early 2020, scientists have struggled to find laboratory models of SARS-CoV-2 infection, the respiratory virus that causes COVID-19. Animal models fell short; attempts to grow adult human lungs have historically failed because not all of the cell types survived. Undaunted, stem cell scientists, cell biologists, infectious
0 Comments
As we get older, it’s more and more likely that more of us will live alone.  According to the latest information from the Merck Manuals, some 28% (14.7 million) of US community-dwelling older adults live alone (21% of older men and 34% of older women). The numbers increase with age – some 44 percent of
0 Comments
An investigational HIV vaccine tested in the “Imbokodo” clinical trial conducted in sub-Saharan Africa posed no safety concerns but did not provide sufficient protection against HIV infection, according to a primary analysis of the study data. The Phase 2b proof-of-concept study, which began in November 2017, enrolled 2,637 women ages 18 to 35 years from
0 Comments
GAITHERSBURG, Md., Aug. 25, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Novavax’ recombinant nanoparticle protein vaccine candidate is being studied in OCTAVE-DUO, now underway in the UK to evaluate the safety and immunogenicity of a third COVID-19 vaccine dose in participants with impaired immune
0 Comments
A new study by researchers at the University of California Los Angeles (UCLA) reports that the best protection against new infections or reinfections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, may be obtained by a combination of vaccine-elicited and infection-induced antibodies to the
0 Comments
NEW YORK–(BUSINESS WIRE) August 30, 2021 — Pfizer Inc. (NYSE: PFE) today announced that JADE DARE (B7451050), a 26-week, randomized, double-blind, double-dummy, active-controlled, multi-center Phase 3 study, met its co-primary and key secondary efficacy endpoints. The study showed that abrocitinib was statistically superior compared to dupilumab in each evaluated efficacy measure and had a safety
0 Comments
Learn how to let go of self-deprecation, and instead talk positively about your achievements Most of us have been there: you are introduced to someone new as, “A talented writer/accountant/marketer/musician” etc. Rather than accept the compliment, chances are you swiftly downplay your strengths, and feel a little embarrassed. But why are we so quick to
0 Comments
We saw this coming. Pediatricians sounded the alarm as cases of viral upper respiratory infections poured into our emergency departments, wards, and pediatric intensive care units (PICUs) earlier this summer. We warned citizens and lawmakers about what might happen if we sent our children back to school without reliable mitigation efforts in place. As a
0 Comments
What is it that makes a simple jigsaw puzzle such an effective mindfulness practice? It’s the rainy day classic that became a lockdown essential, and while there’s nothing new about puzzles (the first jigsaw is thought to have been created in 1762), many of us are just starting to realise the potentially mindful boost that
0 Comments
Note that some links may require registration or subscription. The Education Department has launched investigations into five states over their bans on mask mandates in schools as a civil rights matter. (New York Times) Is the World Health Organization (WHO) softening its stance against COVID booster shots? (Reuters) Some scientists believe coronavirus vaccine-conferred immunity is
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients on immunosuppressive or immunomodulatory therapy should receive a third dose of either the Pfizer-BioNTech COVID-19 vaccine or the Moderna COVID-19 vaccine at least 28 days after the second dose of either of these two mRNA vaccines, according to updated recommendations
0 Comments
Treatment for Prevention of COVID-19 Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of Comirnaty in Individuals 16 and Older New Phase 3 data show booster (third) dose of Comirnaty induces significant SARS-CoV-2 neutralizing antibody titers and demonstrated a favorable safety and tolerability profile SARS-CoV-2 neutralizing
0 Comments
Taiwan is banking on a homegrown Covid-19 shot to speed up its inoculation program as the island and many countries struggle to secure vaccine deliveries from major drug companies. The locally produced Covid vaccine from Medigen Vaccine Biologics was rolled out last week, with President Tsai Ing-wen receiving her first shot of the two-dose vaccine
0 Comments
A new study from the Prevention Research Center of the Pacific Institute for Research and Evaluation finds that recreational marijuana legalization may increase the risk of alcohol and marijuana co-use among adolescents. The study examined the association between recreational marijuana legalization in California in November 2016 and alcohol and marijuana co-use among underage youth. The
0 Comments
Each year, approximately 4,000 children undergo a tracheostomy-;the surgical placement of a breathing tube-;due to respiratory or neuromuscular disorders or chronic disease progression. Bacterial respiratory infections are the most common reason for hospitalization of these children at a cost of $300 million in U. S. hospital charges. In spite of its frequency, there is very
0 Comments
GAITHERSBURG, Md., Aug. 30, 2021. Novavax, Inc. , a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Centers for Disease Control and Prevention (CDC) has provided updated guidance for those who have been vaccinated as part of a clinical trial in the U.S. The CDC guidance states that participants
0 Comments
Public health authorities have been persuading the general masses to get the COVID-19 booster shots once they have become available. But the guidance has mostly been for those who received the mRNA vaccines from Pfizer and Moderna, leaving recipients of Johnson & Johnson’s Janssen vaccine wondering if they also need the additional dose of the vaccine. 
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE) August 20, 2021 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the adjuvant treatment of patients with urothelial carcinoma (UC) who are at
0 Comments